Myc Target 1 anticorps (AA 21-100)

N° du produit ABIN728015

Détail du produit anti-Myc Target 1 anticorps

Antigène: Myc Target 1 (MYCT1)

Épitope: AA 21-100

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Myc Target 1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MTLC

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur Myc Target 1

Antigène: Myc Target 1 (MYCT1)

Autre désignation: MTLC (MYCT1 Produits)

Synonymes: anticorps MYCT1, anticorps MGC147166, anticorps si:dkey-12h9.2, anticorps MTLC, anticorps 1110020B04Rik, anticorps AI225941, anticorps AI642973, anticorps Mtmc1, anticorps myc target 1, anticorps MYC target 1, anticorps myc target 1a, anticorps MYCT1, anticorps myct1, anticorps myct1a, anticorps Myct1

Sujet:

Synonyms: MTLC, Myc target protein 1, Myc target in myeloid cells protein 1, MYCT1, MTMC1

Background: May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity).

ID gène: 80177

UniProt: Q8N699